Urothelial Carcinoma

July 06, 2021

According to the American Urological Association, 72.5% of urologists used Advanced Practice Providers in their practice and these healthcare providers performed a variety of procedures such as a cystoscopy (procedure examining bladder lining), which assists in the diagnosis of bladder cancer. Evidence shows patients have demonstrated a growing acceptance of APPs in urology practice settings.

July 05, 2021

Researchers identified being Black and of the female gender as the strongest predictors of late-stage diagnosis.

June 30, 2021

Results suggest potential for better use of precision medicine approaches.

June 28, 2021

A presentation at the 2021 American Society of Clinical Oncology meeting earlier this month reviewed recent findings from trials investigating the treatment of urothelial cancer.

June 14, 2021

A large proportion of patients with muscle-invasive bladder cancer responded to transurethral resection of bladder tumor and a drug cocktail that included gemcitabine, cisplatin and Opdivo (nivolumab).

June 02, 2021

Tumors glow pink under blue light.

May 25, 2021

A virtual summit on urothelial cancers is scheduled for October.

May 04, 2021

Oncology Analytics senior vice president Laura Bobolt discusses the new indication for Trodelvy and other matters.

May 03, 2021

The antibody-conjugate is also approved as a treatment for metastatic triple negative breast cancer.

May 01, 2021

As hearings of the FDA panel have shown, once a drug is approved and in clinical guidelines, pulling it from the market is not so simple, even if later trials do not confirm phase 2 results.